Arbitel-CT 40 Tablet
By Arbitel-CT
Rx
15 Tablet in a Strip

Composition
Telmisartan(40mg) + Chlorthalidone(12.5mg)

Manufacturer - Micro Labs Ltd
27, RACE COURSE ROAD, BANGALORE-560 001, INDIA

Expires on or after
June, 2026

liver
Arbitel-CT 40 Tablet should be used carefully by individuals with liver disease. It may be necessary to adjust the dosage of Arbitel-CT 40 Tablet for these patients. Consulting your doctor is important in such cases. It is advised not to use Arbitel-CT 40 Tablet in individuals with severe liver disease.

kidney
Arbitel-CT 40 Tablet should be used carefully in severe kidney disease. Dose adjustment may be necessary. Avoid in these patients; consult your doctor.

alcohol
It is unsafe to drink alcohol while taking Arbitel-CT 40 Tablet.

driving
Arbitel-CT 40 Tablet may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Arbitel-CT 40 Tablet is not recommended during pregnancy because it poses risks to the developing baby. In certain life-threatening situations, a doctor might prescribe it if benefits outweigh risks. Always consult your doctor.

breastfeeding
Arbitel-CT 40 Tablet is not recommended for use during breastfeeding as it may cause toxicity to the baby. It is better to consult your doctor before using Arbitel-CT 40 Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹192
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024